1. Peptide Inhibitors of the α-Cobratoxin-Nicotinic Acetylcholine Receptor Interaction.
- Author
-
Lynagh T, Kiontke S, Meyhoff-Madsen M, Gless BH, Johannesen J, Kattelmann S, Christiansen A, Dufva M, Laustsen AH, Devkota K, Olsen CA, Kümmel D, Pless SA, and Lohse B
- Subjects
- Animals, Binding Sites drug effects, Binding Sites physiology, Cobra Neurotoxin Proteins chemistry, Crystallography, X-Ray, Dose-Response Relationship, Drug, Female, Peptide Fragments chemistry, Protein Structure, Secondary, Receptors, Nicotinic chemistry, Xenopus laevis, Cobra Neurotoxin Proteins antagonists & inhibitors, Cobra Neurotoxin Proteins metabolism, Peptide Fragments metabolism, Peptide Fragments pharmacology, Receptors, Nicotinic metabolism
- Abstract
Venomous snakebites cause >100 000 deaths every year, in many cases via potent depression of human neuromuscular signaling by snake α-neurotoxins. Emergency therapy still relies on antibody-based antivenom, hampered by poor access, frequent adverse reactions, and cumbersome production/purification. Combining high-throughput discovery and subsequent structure-function characterization, we present simple peptides that bind α-cobratoxin (α-Cbtx) and prevent its inhibition of nicotinic acetylcholine receptors (nAChRs) as a lead for the development of alternative antivenoms. Candidate peptides were identified by phage display and deep sequencing, and hits were characterized by electrophysiological recordings, leading to an 8-mer peptide that prevented α-Cbtx inhibition of nAChRs. We also solved the peptide:α-Cbtx cocrystal structure, revealing that the peptide, although of unique primary sequence, binds to α-Cbtx by mimicking structural features of the nAChR binding pocket. This demonstrates the potential of small peptides to neutralize lethal snake toxins in vitro, establishing a potential route to simple, synthetic, low-cost antivenoms.
- Published
- 2020
- Full Text
- View/download PDF